Skip to main content
Year archive

NKMAX Co., Ltd. — 2023 filings

All 58 regulatory filings released by NKMAX Co., Ltd. (182400) in 2023, sourced directly from the official regulator.

58 Filings
2023 Period
2023 filings (58)
Filing Released Lang
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings
2023-12-28 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-12-28 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-12-28 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-12-20 Korean
권리락(무상증자)
Share Issue/Capital Change
2023-12-20 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change
2023-12-18 Korean
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount
2023-12-15 Korean
주권매매거래정지(무상증자)
Share Issue/Capital Change
2023-12-06 Korean
주요사항보고서(무상증자결정)
Share Issue/Capital Change
2023-12-06 Korean
주주명부폐쇄기간또는기준일설정
Share Issue/Capital Change
2023-12-06 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-11-22 Korean
[기재정정]반기보고서 (2023.06)
Interim / Quarterly Report H1 2023
2023-11-14 Korean
분기보고서 (2023.09)
Interim / Quarterly Report 9M 2023
2023-11-14 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change
2023-10-20 Korean
풍문또는보도에대한해명(미확정)
Regulatory Filings
2023-10-20 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings
2023-10-19 Korean
전환가액의조정
Share Issue/Capital Change
2023-10-16 Korean
[기재정정]주권관련사채권의취득결정
Capital/Financing Update
2023-10-10 Korean
[기재정정]주권관련사채권의취득결정
Capital/Financing Update
2023-10-10 Korean
투자판단관련주요경영사항(임상시험계획변경승인)(표준요법에 실패한 전이 또는 국소적으로 진행된 고형암 환자를 대상으로 SNK02 정맥 투여의 내약성,안전성 평가 및 항종양 효과 탐색을 위한 공개,용량대조,3+3 설계,용량증량,다기관,1상 임상시험 계획 변경 승인)
Regulatory Filings
2023-10-10 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-10-06 Korean
풍문또는보도에대한해명(미확정)
Regulatory Filings
2023-10-06 Korean
해외증권시장주권등상장(종속회사의주요경영사항)
Delisting Announcement
2023-10-04 Korean
주권관련사채권의취득결정
Capital/Financing Update
2023-09-15 Korean
증권발행결과(자율공시)
Capital/Financing Update
2023-09-13 Korean
증권발행결과(자율공시)
Capital/Financing Update
2023-09-12 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-09-11 Korean
주요사항보고서(신주인수권부사채권발행결정)
Capital/Financing Update
2023-09-11 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update
2023-09-08 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-08-17 Korean
반기보고서 (2023.06)
Interim / Quarterly Report H1 2023
2023-08-14 Korean
단일판매ㆍ공급계약체결
Regulatory Filings
2023-07-21 Korean
전환가액의조정
Share Issue/Capital Change
2023-07-17 Korean
[기재정정]전환가액의조정
Capital/Financing Update
2023-07-17 Korean
풍문또는보도에대한해명(미확정)
Regulatory Filings
2023-07-07 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-07-06 Korean
풍문또는보도에대한해명(미확정)
Regulatory Filings
2023-06-19 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-06-09 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-06-02 Korean
풍문또는보도에대한해명(미확정)
Regulatory Filings
2023-05-18 Korean
분기보고서 (2023.03)
Interim / Quarterly Report Q1 2023
2023-05-15 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-04-21 Korean
회사합병결정(종속회사의주요경영사항)
M&A Activity
2023-04-17 Korean
해외증권시장주권등상장결정(종속회사의주요경영사항)
Delisting Announcement
2023-04-17 Korean
[기재정정]투자판단관련주요경영사항(NK세포 치료제 특허 관련 기술 이전 계약)
M&A Activity
2023-04-11 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-03-29 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2023-03-29 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-03-21 Korean
감사보고서제출
Audit Report / Information FY 2022
2023-03-20 Korean
사업보고서 (2022.12)
Annual Report FY 2022
2023-03-20 Korean
주주총회소집결의
AGM Information
2023-03-14 Korean
주주총회소집공고
AGM Information
2023-03-14 Korean
전환가액의조정
Share Issue/Capital Change
2023-03-10 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-03-03 Korean
투자판단관련주요경영사항(표준요법에 실패한 전이 또는 국소적으로 진행된 고형암 환자를 대상으로 SNK02 정맥 투여의 내약성,안전성 평가 및 항종양 효과 탐색을 위한 공개,용량대조,3+3 설계,용량증량,다기관,1상 임상시험 계획 변경 신청)
Regulatory Filings
2023-03-03 Korean
전환가액의조정
Share Issue/Capital Change
2023-03-02 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-02-17 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-01-10 Korean